SCHEMBL22014399

SCHEMBL22014399

CC1(C)OCc2c1cc(Br)c(N)c2Br

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21962217 0.69
SCHEMBL34471708 0.68 PGR (0.30)
SCHEMBL21962328 0.66
SCHEMBL34473201 0.66 PGR (0.33)
SCHEMBL34471998 0.66 PGR (0.33)
SCHEMBL22014396 0.65
SCHEMBL24822945 0.64 BCHE (0.33)
SCHEMBL31394389 0.64
SCHEMBL31394771 0.63 PGR (0.33)
SCHEMBL21962186 0.63 GAA (0.34) GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102574-A1 THE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed